Table of Contents
Research & Development
| Merck Signs Two Oncology Collaborations with Seattle Genetics | Abstract pdf html |
| Michelle Liu |
Licensing
| Sanofi Delves Further into Protein Degrader Therapies with US$2.33 B Kymera Deal | Abstract pdf html |
| Ashish Tripathi & Michelle Liu |
Mergers & Acquisitions
| Gilead Continues Immuno-oncology Spree with US$21 B Immunomedics Buy | Abstract pdf html |
| Michelle Liu |
Opinion & Analysis
| IQVIA Pharma Deals Half-Year Review of 2020 | Abstract pdf |
| Heather Cartwright, Michelle Liu & Taskin Ahmed |
This work is licensed under a Creative Commons Attribution 3.0 License.